| Cardiovascular therapy use, modification, and in-hospital death in patients with COVID-19: A cohort study | PloS one |  | | 2022 | 107 | 162 |
|
| Mortality and high risk of major adverse events in patients with COVID-19 and history of cardiovascular disease | Open Heart | | | 2021 | 259 | 239 |
|
| Hepatitis C prevalence in the psychiatric setting: cost-effectiveness of scaling-up screening and direct-acting antiviral therapy | JHEP Reports : Innovation in Hepatology | | | 2021 | 313 | 229 |
|
| Symptoms and quality of life at 1-year follow up of patients discharged after an acute COVID-19 episode | Schweizerische medizinische Wochenschrift | | | 2021 | 299 | 163 |
|
| Emerging Concepts and Applied Machine Learning Research in Patients with Drug-Induced Repolarization Disorders | Studies in Health Technology and Informatics | | | 2020 | 519 | 293 |
|
| Direct-acting antiviral interactions with opioids, alcohol or illicit drugs of abuse in HCV-infected patients | Liver International | | | 2020 | 362 | 598 |
|
| Modelling the Impact and Cost-Effectiveness of Extended Screening and Treatment with Direct-Acting Antivirals in a Swiss Custodial Setting | Clinical Infectious Diseases | | | 2019 | 434 | 369 |
|
| Increasing hepatitis C virus screening in people who inject drugs in Switzerland using rapid antibody saliva and dried blood spot testing: A cost-effectiveness analysis | Journal of Viral Hepatitis |  | | 2019 | 452 | 1 |
|
| Coinfections between Persistent Parasitic Neglected Tropical Diseases and Viral Infections among Prisoners from Sub-Saharan Africa and Latin America | Journal of Tropical Medicine | | | 2018 | 758 | 381 |
|
| Blood-borne and sexually transmitted infections: a cross-sectional study in a Swiss prison | BMC Infectious Diseases | | | 2018 | 362 | 288 |
|
| Cost-effectiveness of HLA-DQB1/HLA-B pharmacogenetic-guided treatment and blood monitoring in US patients taking clozapine | The Pharmacogenomics Journal | | | 2018 | 669 | 411 |
|
| Health technology assessment: a framework for economic evaluations in policy guidance and medical management | | | | 2017 | 473 | 8 |
|
| Health utility indexes in patients with acute coronary syndromes | Open heart | | | 2016 | 573 | 290 |
|
| Early Discharge in Low-Risk Patients Hospitalized for Acute Coronary Syndromes: Feasibility, Safety and Reasons for Prolonged Length of Stay | PloS one | | | 2016 | 865 | 448 |
|
| Early specialized care after a first unprovoked epileptic seizure | Journal of neurology | | | 2016 | 685 | 2 |
|
| Drug Pricing Evolution in Hepatitis C | PloS one | | | 2016 | 1,377 | 699 |
|
| Electrocardiographic Screening for Prolonged QT Interval to Reduce Sudden Cardiac Death in Psychiatric Patients: A Cost-Effectiveness Analysis | PloS one | | | 2015 | 537 | 383 |
|
| Repenser la politique de remboursement des agents antiviraux directs contre l'hépatite C chronique | Revue médicale suisse | | | 2015 | 557 | 1 |
|
| Monitoring white blood cell count in adult patients with schizophrenia who are taking clozapine: a cost-effectiveness analysis | The Lancet. Psychiatry | | | 2014 | 570 | 0 |
|
| Patented drug extension strategies on healthcare spending: a cost-evaluation analysis | PLoS medicine | | | 2013 | 759 | 430 |
|
| Drug-induced long QT in adult psychiatric inpatients: the 5-year cross-sectional ECG Screening Outcome in Psychiatry study | The American journal of psychiatry | | | 2013 | 695 | 1 |
|
| Enseignement de recommandations pour la pratique: la prescription médicale au cabinet | Revue médicale suisse | | | 2013 | 435 | 254 |
|
| Liver kidney microsomal type 1 antibodies reduce the CYP2D6 activity in patients with chronic hepatitis C virus infection | Journal of viral hepatitis | | | 2012 | 674 | 0 |
|
| Sélection d'un médicament dans une classe thérapeutique donnée : l'exemple des «inhibiteurs de l'HMG-CoA réductase» | Revue médicale suisse | | | 2005 | 398 | 0 |
|
| Rofecoxib interaction with oral anticoagulant acenocoumarol | European journal of clinical pharmacology | | | 2003 | 489 | 293 |
|
